1012 TELBIVUDINE-INDUCED HBEAG SEROCONVERSION IN CHRONIC HEPATITIS B (CHB) IS DURABLE DURING 2 YEARS OFF-TREATMENT FOLLOW-UP

✍ Scribed by Liaw, Y.-F.; Wursthorn, K.; Thongsawat, S.; Zhou, X.-Q.; Hwang, S.G.; Chutaputti, A.; Teo, E.K.; Gane, E.J.; Jung, M.; Wedemeyer, H.; Avila, C.

• Book ID: 122770557
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 49 KB
• Volume: 52
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(10)61013-6